Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
SNX Transcript
TD SYNNEX Corporation (SNX) Q1 2026 Earnings Call Transcript
Unknown3-31
The earnings call reveals a decline in revenue, operating income, net income, and EPS year-over-year, indicating financial struggles. While gross margin and cash flow from operations have improved, the negative trends in key financial metrics overshadow these positives. The lack of discussion on operational updates and shareholder returns further contributes to uncertainty. The presence of forward-looking statements with risks and uncertainties adds to the negative sentiment. Overall, the financial performance and lack of clarity in management responses suggest a negative outlook for the stock price in the short term.
TD SYNNEX Corporation (SNX) Q4 2025 Earnings Call Transcript
Positive1-8
The earnings call summary highlights strong financial performance, significant market share gains in APJ and Europe, and robust growth in Hyve and AI investments. Despite concerns about component costs, no demand destruction was observed, and optimistic guidance was provided. The Q&A session revealed sustainable growth strategies and positive market sentiment, with Hyve's strong margin profile and strategic technology growth as key factors. Overall, the positive elements outweigh the concerns, suggesting a positive stock price movement.
TD SYNNEX Corporation (SNX) Q3 2025 Earnings Call Transcript
Positive9-25
The earnings call summary highlights strong financial performance, with record high revenue and earnings growth, exceeding guidance. The Q&A section confirms sustained demand and growth in key areas, such as Hyve and PCs, with positive expectations for Q4. Shareholder returns through dividends and buybacks further support a positive outlook. Despite some uncertainty in management's responses, overall sentiment is positive, indicating a likely stock price increase of 2% to 8%.
TD SYNNEX Corporation (SNX) Q2 2025 Earnings Call Transcript
Positive6-24
The earnings call summary indicates strong growth in strategic technologies and partner expansion, with a positive outlook for Q2 net revenue and non-GAAP net income. Shareholder returns are robust, with significant share repurchases and dividends. The Q&A section reveals cautious optimism due to macro uncertainties but highlights strong demand and growth in key areas. Despite some uncertainties, the overall sentiment is positive, with expectations of continued growth and financial health improvements. The commitment to a $1.1 billion free cash flow target and strong performance in APJ further support a positive outlook.
SNX Slides
SNX Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
